April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Neurogenic Inflammation of the Ocular Surface
Author Affiliations & Notes
  • F. Mantelli
    Ophthalmology, Campus Bio-Medico University, Rome, Italy
  • A. Micera
    Ophthalmology, Campus Bio-Medico University, Rome, Italy
    GB Bietti Eye Foundation, Rome, Italy
  • M. Sacchetti
    Ophthalmology, Campus Bio-Medico University, Rome, Italy
  • S. Speranza
    Arma dei Carabinieri Headquarter, Rome, Italy
  • A. Lambiase
    Ophthalmology, Campus Bio-Medico University, Rome, Italy
  • G. Petrachi
    Arma dei Carabinieri Headquarter, Rome, Italy
  • S. Bonini
    Ophthalmology, Campus Bio-Medico University, Rome, Italy
  • Footnotes
    Commercial Relationships  F. Mantelli, None; A. Micera, None; M. Sacchetti, None; S. Speranza, None; A. Lambiase, None; G. Petrachi, None; S. Bonini, None.
  • Footnotes
    Support  Agenzia Italiana del Farmaco (AIFA)
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 4869. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      F. Mantelli, A. Micera, M. Sacchetti, S. Speranza, A. Lambiase, G. Petrachi, S. Bonini; Neurogenic Inflammation of the Ocular Surface. Invest. Ophthalmol. Vis. Sci. 2010;51(13):4869.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Neurogenic inflammation plays a crucial role in allergic and autoimmune diseases. Sensory and autonomic nerve fibers release neuromediators, which trigger and modulate neurogenic inflammation. Although the cornea is the most densely innervated tissue of the human body, little is known about the role of neuromediators at the ocular surface. We aimed at evaluating the role of the following neuromediators in inflammatory conditions of the ocular surface: Substance P (SP), Calcitonine Gene Related Peptide (CGRP), Neuropeptide Y (NPY) and Vasoactive Intestinal Peptide (VIP).

Methods: : 19 patients with dry eye (4M, 15F; mean age 64±14 years), 14 with allergic conjunctivitis (5F, 9M, mean age 30±9 years) in non-active phase and 12 healthy subjects (8 males and 4 females; mean age 41±21 years), were included in this study. Conjunctival provocation test (CPT) with allergen was performed in all allergic patients. Tear samples were collected and the tear content of VIP, NPY, CGRP and SP was measured by ELISA at baseline and after CPT. Mann-Whitney U-test was used to compare neuromediators’ levels and Spearman-rho correlation analysis was performed to identify relationships with clinical parameters.

Results: : No significant differences were observed between healthy and allergic patients without symptoms. In allergic patients SP, CGRP and VIP were significantly higher after CPT (SP: 3.2 (0.1-5.9) g/ml versus 5.1 (0.8-7.4)ng/ml, p=0.018; CGRP:5.5 (1.9-10.3)ng/ml versus 6 (2.4-10.9) ng/ml; p=0.006; VIP: 3.9 (2.7-5.6) g/ml versus 5.3 (2.3-7.5)ng/ml, p=0.019). Patients with dry eye showed a significant decrease in tear levels of CGRP (median: 3 ng/ml (range: 0.2-9.3 ng/ml) vs. 5.8 ng/ml (2.5-10.5 ng/ml); p=0.001) and NPY (1.6 ng/ml (0.2-9.6 ng/ml) vs 4.3 ng/ml (1.6-33.1 ng/ml); p=0.015). In dry eye patients, CGRP and NPY showed a direct correlation with Schirmer test (p=0.010, p=0.042; respectively) and an inverse correlation with Oxford score (p<0.001, p=0.006), and NPY inversely correlated to tear film break-up time (p=0.006).

Conclusions: : Locally-released neuromediators may be crucial to modulate inflammatory responses of the ocular surface. Further studies will be needed to identify the specific role of different neuromediators in ocular surface diseases.

Keywords: cornea: clinical science • neuropeptides • inflammation 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.